A
AHCO
Adapthealth Corp
9.97
-0.16-1.58%Opening15:35 06/01 EDT
OPEN/PREV CLOSE10.06/10.13
TODAY RANGE9.72-10.15
VOL1.15M
MARKET CAP1.36B
52 WEEK RANGE8.06-13.43
AVG VOL (3M)1.48M
% TURNOVER0.84%
TURNOVER--
P/E (TTM)-16.7450
% RANGE4.24%
EPS(TTM)-0.5954
P/E(FORWARD)13.85
P/B0.8998
BVPS11.08
DIVIDEND--
P/S0.4162
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.08B
SHARES OUTSTANDING136.05M
NEXT EARNINGS08/03-08/07
FREE FLOAT108.76M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·05/11 14:31
AdaptHealth Is Maintained at Outperform by RBC Capital
Dow Jones·05/11 14:31
AdaptHealth Price Target Raised to $15.00/Share From $13.00 by RBC Capital
Benzinga·05/11 14:21
RBC Capital Maintains Outperform on AdaptHealth, Raises Price Target to $15
TipRanks·05/11 12:33
AdaptHealth (AHCO) Gets a Buy from RBC Capital
TipRanks·05/07 09:26
AdaptHealth price target raised to $18 from $17 at Baird
TipRanks·05/07 07:38
AdaptHealth price target raised to $16 from $14 at Canaccord
Dow Jones·05/06 23:06
AdaptHealth Is Maintained at Buy by Canaccord Genuity
Dow Jones·05/06 23:06
AdaptHealth Price Target Raised to $16.00/Share From $14.00 by Canaccord Genuity
Benzinga·05/06 22:56
Canaccord Genuity Maintains Buy on AdaptHealth, Raises Price Target to $16
Dow Jones·05/06 21:43
AdaptHealth Is Maintained at Buy by UBS
Dow Jones·05/06 21:43
AdaptHealth Price Target Cut to $14.00/Share From $15.00 by UBS
Benzinga·05/06 21:34
UBS Maintains Buy on AdaptHealth, Lowers Price Target to $14
Reuters·05/06 12:37
ADAPTHEALTH CORP <AHCO.O>: UBS CUTS TARGET PRICE TO $14 FROM $15
TipRanks·05/06 12:12
Truist Financial Sticks to Their Buy Rating for AdaptHealth (AHCO)